Literature DB >> 17174789

Positron emission tomography myocardial perfusion and glucose metabolism imaging.

Josef Machac, Stephen L Bacharach, Timothy M Bateman, Jeroen J Bax, Robert Beanlands, Frank Bengel, Steven R Bergmann, Richard C Brunken, James Case, Dominique Delbeke, Marcelo F DiCarli, Ernest V Garcia, Richard A Goldstein, Robert J Gropler, Mark Travin, Randolph Patterson, Heinrich R Schelbert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17174789     DOI： 10.1016/j.nuclcard.2006.08.009

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   3.872


× No keyword cloud information.
  81 in total

1.  Common artifacts in PET myocardial perfusion images due to attenuation-emission misregistration: clinical significance, causes, and solutions.

Authors:  Catalin Loghin; Stefano Sdringola; K Lance Gould
Journal:  J Nucl Med       Date:  2004-06       Impact factor: 10.057

2.  N-13 ammonia as an indicator of myocardial blood flow.

Authors:  H R Schelbert; M E Phelps; S C Huang; N S MacDonald; H Hansen; C Selin; D E Kuhl
Journal:  Circulation       Date:  1981-06       Impact factor: 29.690

3.  A reverse flow-metabolism mismatch pattern on PET is related to multivessel disease in patients with acute myocardial infarction.

Authors:  H Yamagishi; K Akioka; K Hirata; Y Sakanoue; K Takeuchi; J Yoshikawa; H Ochi
Journal:  J Nucl Med       Date:  1999-09       Impact factor: 10.057

4.  Regional wall thickening of left ventricle evaluated by gated positron emission tomography in relation to myocardial perfusion and glucose metabolism.

Authors:  K Yamashita; N Tamaki; Y Yonekura; H Ohtani; Y Magata; R Nohara; H Kambara; C Kawai; T Ban; J Konishi
Journal:  J Nucl Med       Date:  1991-04       Impact factor: 10.057

5.  Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging.

Authors:  R S Beanlands; P J Hendry; R G Masters; R A deKemp; K Woodend; T D Ruddy
Journal:  Circulation       Date:  1998-11-10       Impact factor: 29.690

6.  A procedure for patient repositioning and compensation for misalignment between transmission and emission data in PET heart studies.

Authors:  V Bettinardi; M C Gilardi; G Lucignani; C Landoni; G Rizzo; G Striano; F Fazio
Journal:  J Nucl Med       Date:  1993-01       Impact factor: 10.057

7.  Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution.

Authors:  K Hamacher; H H Coenen; G Stöcklin
Journal:  J Nucl Med       Date:  1986-02       Impact factor: 10.057

8.  Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET.

Authors:  T Ohtake; I Yokoyama; T Watanabe; T Momose; T Serezawa; J Nishikawa; Y Sasaki
Journal:  J Nucl Med       Date:  1995-03       Impact factor: 10.057

9.  Coronary revascularization in the treatment of moderate and severe postischemic left ventricular dysfunction.

Authors:  F Fath-Ordoubadi; D Pagano; N V Marinho; B E Keogh; R S Bonser; P G Camici
Journal:  Am J Cardiol       Date:  1998-07-01       Impact factor: 2.778

10.  Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans.

Authors:  C Depré; J L Vanoverschelde; J A Melin; M Borgers; A Bol; J Ausma; R Dion; W Wijns
Journal:  Am J Physiol       Date:  1995-03
View more
  40 in total

1.  Ischemic changes on rubidium-82 positron emission tomography imaging are associated with left ventricular functional and volumetric change independent of metabolic properties and echocardiographic functional variables in ischemic cardiomyopathy.

Authors:  Raymond C Wong; Manuel D Cerqueira; Richard C Brunken
Journal:  Int J Cardiovasc Imaging       Date:  2011-11-11       Impact factor: 2.357

2.  Reduced septal glucose metabolism predicts response to cardiac resynchronization therapy.

Authors:  David Birnie; Rob A de Kemp; Anthony S Tang; Terence D Ruddy; Michael H Gollob; Ann Guo; Kathryn Williams; Kerry Thomson; Jean N DaSilva; Rob S Beanlands
Journal:  J Nucl Cardiol       Date:  2011-12-10       Impact factor: 5.952

3.  Quantitative analysis of coronary endothelial function with generator-produced 82Rb PET: comparison with 15O-labelled water PET.

Authors:  Keiichiro Yoshinaga; Osamu Manabe; Chietsugu Katoh; Li Chen; Ran Klein; Masanao Naya; Robert A deKemp; Kathryn Williams; Rob S B Beanlands; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-13       Impact factor: 9.236

4.  Viability assessment with MRI is superior to FDG-PET for viability: Con.

Authors:  Randolph E Patterson; Steven R Sigman; Robert E O'Donnell; Robert L Eisner
Journal:  J Nucl Cardiol       Date:  2010-04       Impact factor: 5.952

Review 5.  Assessment of coronary endothelial function using PET.

Authors:  Keiichiro Yoshinaga; Osamu Manabe; Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2011-05       Impact factor: 5.952

6.  Cardiac 82Rubidium PET/CT: initial European experience.

Authors:  Ashley M Groves; Marie-Elsya Speechly-Dick; John C Dickson; Irfan Kayani; Raymondo Endozo; Patty Blanchard; Manu Shastry; Elizabeth Prvulovich; Wendy A Waddington; Simona Ben-Haim; Jamshed B Bomanji; Jean R McEwan; Peter J Ell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-08-31       Impact factor: 9.236

Review 7.  Imaging the myocardial ischemic cascade.

Authors:  Arthur E Stillman; Matthijs Oudkerk; David A Bluemke; Menko Jan de Boer; Jens Bremerich; Ernest V Garcia; Matthias Gutberlet; Pim van der Harst; W Gregory Hundley; Michael Jerosch-Herold; Dirkjan Kuijpers; Raymond Y Kwong; Eike Nagel; Stamatios Lerakis; John Oshinski; Jean-François Paul; Riemer H J A Slart; Vinod Thourani; Rozemarijn Vliegenthart; Bernd J Wintersperger
Journal:  Int J Cardiovasc Imaging       Date:  2018-03-19       Impact factor: 2.357

Review 8.  Ischaemic memory imaging using metabolic radiopharmaceuticals: overview of clinical settings and ongoing investigations.

Authors:  Keiichiro Yoshinaga; Masanao Naya; Tohru Shiga; Eriko Suzuki; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-12       Impact factor: 9.236

9.  Preliminary data on the diagnostic accuracy of rubidium-82 cardiac PET perfusion imaging for the evaluation of ischemia in a pediatric population.

Authors:  Adnan K Chhatriwalla; Lourdes R Prieto; Richard C Brunken; Manuel D Cerqueira; Adel Younoszai; Wael A Jaber
Journal:  Pediatr Cardiol       Date:  2008-05-06       Impact factor: 1.655

10.  Rubidium-82 PET-CT for quantitative assessment of myocardial blood flow: validation in a canine model of coronary artery stenosis.

Authors:  Riikka Lautamäki; Richard T George; Kakuya Kitagawa; Takahiro Higuchi; Jennifer Merrill; Corina Voicu; Anthony DiPaula; Stephan G Nekolla; João A C Lima; Albert C Lardo; Frank M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-05       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.